Overview
Index page for MiCA Q&A subcategory pages.
Submitted MiCAR Q&As that are either still under review by the EBA/ESMA/European Commission or that have been rejected by the answering body. The Q&A text and the rationale (for rejections) are preserved here for reference even though no official answer is published.
Under Review
Are ART reserve liabilities secured, and therefore excluded from bail-in in resolution?
36(2)
26 Apr 2024
Can technically identical EMTs be issued in parallel by EU and non-EU entities?
48, 49, 54, 56
29 Apr 2024
What is the scope of Recital 54 and Article 54 of MiCAR regarding 'significant' ARTs and EMTs?
54, Recital 54
29 Apr 2024
Rejected
How can the MiCAR authority access prudential information for assessing ART/EMT recovery plans?
46, 47, 55
15 Nov 2024
What own funds must ART issuers exempt from authorisation under Article 16(2) hold?
35(1)
21 Nov 2024
Can a CASP receive, transmit or execute orders for non-EUR EMTs from non-MiCA-compliant issuers?
48(1)
24 Jul 2025
Must banks maintain a segregated account to safeguard proceeds from EMT issuance?
54, 58
11 Nov 2025
How are own funds determined for an entity with simultaneous CASP, EMI and investment firm authorisations?
67
29 May 2026
Related
investment firm β defined term used on this page
investment firm β defined term used on this page
investment firm β defined term used on this page
investment firm β defined term used on this page
funds β defined term used on this page
funds β defined term used on this page
funds β defined term used on this page
Last updated